focus -WSS

focus

author：comprehensive 2025-09-29 01:09:04 - browse：174

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： What to expect at HLTH 2023, the health care industry conference

Wikipedia

WSS

AI can decode, harness the power of the humane immune system

Commercial surrogacy can be ethical, despite pope’s claims

A Q&A with the global head of Boehringer Ingelheim's innovation unit

SAMSHA loosens regulations on methadone treatment centers

Commercial surrogacy can be ethical, despite pope’s claims

Was Amgen transparent enough on FDA's concern on cancer drug?

hotspot

focus

explore

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Medical leaders decry Supreme Court decision on affirmative action

Novo Nordisk to expand supply of Wegovy for U.S. patients

Anesthesiologist group: stop taking Ozempic before surgery

Time to name cancers by genetics, not organ of origin, expert says

Walensky prepares to leave CDC — and Congress — behind

When women are denied an abortion, their children fare worse than peers

Psychedelics group wrestles with new pharma identity

3 questions for the future of Biden's cancer moonshot

hotspot

Cognito secures funding to test medical device for Alzheimer's

ARCH Venture Partners is raising $3 billion for a life sciences fund

A $475,000 price tag for a new cancer drug: crazy or meh?

Time to name cancers by genetics, not organ of origin, expert says

Was Amgen transparent enough on FDA's concern on cancer drug?

FDA authorizes Novavax’s updated Covid

Wikipedia

Wikipedia

hotspot

hotspot